prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, Specimen #: Race: BLACK. Physician (s) : AMENDED. SPECIMEN: A: RIGHT SENTINEL LYMPH NODE #1. B: LEFT SENTINEL LYMPH NODE #1 C: LEFT BREAST LUMPECTOMY. D: LEFT BREAST FINAL SUPERIOR MARGIN. E: RIGHT BREAST LUMPECTOMY. FINAL DIAGNOSIS: A. LYMPH NODE, RIGHT SENTINEL #1, EXCISION: - NEGATIVE FOR MALIGNANCY BY H&E AND CYTOKERATIN IMMUNOHISTOCHEMISTRY. B. LYMPH NODE, LEFT SENTINEL #1, EXCISON: - NEGATIVE FOR MALIGNANCY BY H&E AND CYTOKERATIN IMMUNOHISTOCHEMISTRY. C. BREAST, LEFT, 9:00 POSITION, NEEDLE LOCALIZATION, LUMPECTOMY: - PAPILLARY CARCINOMA IN-SITU WITH SURROUNDING DUCTAL. CARCINOMA IN-SITU, COMEDO TYPE (SEE COMMENT) . - TUMOR SIZE: 1.2 CM (GROSS MEASURMENT). - LOBULAR CARCINOMA IN-SITU, MULTIFOCAL. - DUCTAL CARCINOMA IN-SITU IS PRESENT LESS THAN 1.0 MM FROM SUPERIOR. MARGIN (NOTE: SPECIMEN D, DESIGNATED "FINAL SUPERIOR MARGIN" IS. NEGATIVE FOR TUMOR). - MICROCALCIFICATIONS IDENTIFIED IN DUCTAL CARCINOMA IN-SITU AND BENIGN. BREAST TISSUE. D. BREAST, LEFT, FINAL SUPERIOR MARGIN, EXCISON. - BENIGN BREAST TISSUE. - NEGATIVE FOR MALIGNANCY. E. BREAST, RIGHT, 6:00 POSITION, NEEDLE LOCALIZATION, LUMPECTOMY: - INFILTRATING DUCTAL ADENOCARCINOMA, MODERATELY DIFFERENTIATED BY. COMBINED NUCLEAR-HISTOLOGIC GRADE. - MAXIMUM TUMOR DIMENSION 1.8 CM (INVASIVE COMPONENT, MICROSCOPIC. MEASUREMENT). - ASSOCIATED PAPILLARY CARCINOMA AND DUCTAL CARCINOMA IN-SITU,. NUCLEAR GRADE 2 WITH NECROSIS. - LOBULAR CARCINOMA IN-SITU, MULTIFOCAL. Specimen #: FINAL DIAGNOSIS (continued) : - INVASIVE CARCINOMA INVOLVES THE SUPERIOR MARGIN, IS LESS THAN 1.0 MM. FROM THE ANTERIOR MARGIN, AND IS 1.5 MM FROM THE POSTERIOR MARGIN. INTRADUCTAL PAPILLARY CARCINOMA IS PRESENT LESS THAN 1.0 MM FROM. THE POSTERIOR MARGIN. - MICROCALCIFICATIONS IDENTIFIED IN DUCTAL CARCINOMA IN-SITU AND BENIGN. BREAST TISSUE. - AJCC STAGE: pT1 pNO(i-) MX. COMMENT: On interdepartmental review, slide C4 (left breast) shows an area. suspicious for invasive, micropapillary carcinoma. The size of this focus. is 1. 7mm. was notified of this amended diagnosis on. at. HRS by 1. CLINICAL DIAGNOSIS AND HISTORY: year-old female status post core biopsies, bilateral breast consistent. with, on the right, infiltrating ductal carcinoma; on the left DCIS with. cribiform features. GROSS DESCRIPTION: A. RIGHT SENTINEL LYMPH NODE #1 Received fresh, labeled with the patient's S. name, designated "RIGHT SENTINEL LYMPH NODE #1". The specimen consists of. a piece of fatty tissue, 3.0 cm x 1.7 cm x 0.2 cm, containing a 1.2 cm. lymph node. A small portion of this node is submitted for the CBCP. protocol. B. LEFT SENTINEL LYMPH NODE #1 Received fresh, labeled with the patient's. name, designated "LEFT SENTINEL LYMPH NODE #1". The specimen consists of a. 1.2 cm lymph node. A small portion is submitted for the CBCP protocol. C. LEFT BREAST LUMPECTOMY Received fresh, labeled with the patient's. name, designated "LEFT BREAST LUMPECTOMY 9:00 POSITION (NEEDLE. LOCALIZATION) ". The specimen consists of a piece of fatty tissue, 9.8 cm x. 5.0 cm x 1.4 cm with an overlying ellipse of brown skin, 2.4 cm x 0.3 cm. A needle localization wire is in place and enters the specimen anteriorly,. Specimen #: GROSS DESCRIPTION (continued) : through the skin. The accompanying radiograph is reviewed and shows a. well-defined density anteriorly. The specimen is oriented with sutures. and. inked as follows: Yellow=medial, red=lateral, blue=superior,. green=superior, black=posterior. Sectioning anterior to posterior reveals. a well-defined, 1.2 cm tan, friable lesion with focal cavitation and. hemorrhage anteriorly. Two sections of this lesion, as well as a section. of skin and grossly normal fibrofatty tissue are submitted for the CBCP. protocol (matching paraffin sections=C2-C4, C1, and C5 respectively). Sections are submitted from anterior to posterior. Slide key: C1: Skin. C2-C4: Tumor. C5: Representative normal. C6-C7: Single representative section. C8-C10: Single representative section. C11-C12: Single representative section. C13: Single representative. section. C14-C16: Single representative section. C11-C16 sections. through the area sampled for CBCP protocol. C17-C18: Representative. section. C20-21: Representative sections. C22: Cassette not submitted. C23-25: Representative sections. D. LEFT BREAST FINAL SUPERIOR MARGIN Received fresh, labeled with the. patient's name, designated "LEFT BREAST FINAL SUPERIOR MARGIN". The. unorientated specimen consists of a 4.5 cm x 2.1 cm x 0.5 cm fatty tissue. fragment. Serial sectioning reveals abundant yellow adipose tissue admixed. with a moderate amount of white, dense, interdigitating fibrous tissue. One side is arbitrarily inked in black. E. RIGHT BREAST LUMPECTOMY Received fresh, labeled with the patient's. name, designated "RIGHT BREAST LUMPECTOMY 6:00". The specimen consists of. a piece of fatty tissue, 8.5 cm x 4.5 cm x 2.8 cm impaled with a needle. localization wire. A radiograph accompanies the specimen and shows a. vell-defined mass. The specimen is oriented with sutures; per discussion. with Dr. the long stitch indictates lateral and the short stitch. superior. Ink code: Red=medial and lateral, blue=superior, green=inferior,. yellow=anterior, black=posterior. On sectioning, the specimen reveals a. firm, well-defined, tan tumor, 2.2 cm in greatest dimension, closely. approximating the black inked margin. A portion of the tumor appears. tan and friable. One section of tumor and one section of fibrofatty. tissue is submitted for CBCP protocol (matching paraffin sections-E1 and. E2 respectively). Slide key: E1: Tumor. E2: Rest of the fibrofatty tissue. E3-E6: Single. Specimen #: GROSS DESCRIPTION (continued) : representative sections medial to lateral. E7-E10: - Mass. E11-E13 : Sections. through area of E1 mass. E14-E16: Single section of adjacent mass. E17-E19 - Single section of adjacent mass. E20: Representative section. E21: Lateral portion. 21CF.

expanded version (tokens=2164) : 
 Histological classification: The patient has LumA subtype breast cancer.
Subtype: Luminal A (LumA)
Description of necrosis: Necrosis is present in the ductal carcinoma in-situ and papillary carcinoma associated with invasive ductal carcinoma in the right breast.
Tumor infiltrating lymphocytes: No mention of TILs in the report
Histological grade: Moderately differentiated with combined nuclear-histologic grade
Nuclear grade: Nuclear grade 2
Lymphovascular invasion: Not mentioned in the report
Calcification: Microcalcifications identified in ductal carcinoma in-situ and benign breast tissue
Receptor status: Not mentioned in the report
IHC: Cytokeratin immunohistochemistry was used to confirm the absence of malignancy in the sentinel lymph nodes (A and B).
Ancillary testing results: The size of the left breast tumor is 1.2 cm, while the maximum tumor dimension of the invasive ductal carcinoma in the right breast is 1.8 cm. Lobular carcinoma in-situ (LCIS) was found to be multifocal in both breasts. Microcalcifications were identified in ductal carcinoma in-situ and benign breast tissue. The left breast tumor was papillary carcinoma in-situ with surrounding ductal carcinoma in-situ, comedo type. Intraductal papillary carcinoma is present less than 1.0 mm from the posterior margin in the right breast. The invasive carcinoma involves the

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2345) : 
 The patient has LumA subtype breast cancer with papillary and ductal carcinoma in-situ in the left breast and invasive ductal carcinoma, nuclear grade 2 with necrosis in the right breast. Lobular carcinoma in-situ was multifocal in both breasts. Microcalcifications were identified. Lymph nodes were negative for malignancy, and no lymphovascular invasion was mentioned. Receptor status and IHC results were not included in the report. The left superior margin was negative for tumor, while intraductal papillary carcinoma was present inferiorly to the invasive component on the right side less than 1.0 mm away from the posterior margin.

